Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.
Article
Google Scholar
Santos-Sanchez V, Cordoba-Dona JA, Viciana F, Escolar-Pujolar A, Pozzi L, Ramis R. Geographical variations in cancer mortality and social inequalities in southern Spain (Andalusia). 2002-2013. PLoS One. 2020;15(5):e0233397.
Article
CAS
Google Scholar
Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol. 2006;12(3):354–62.
Article
Google Scholar
Hussain SP, Hollstein MH, Harris CC. p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology, and human risk assessment. Ann N Y Acad Sci. 2000;919:79–85.
Article
CAS
Google Scholar
Alexandrov LB, Stratton MR. Mutational signatures: the patterns of somatic mutations hidden in cancer genomes. Curr Opin Genet Dev. 2014;24:52–60.
Article
CAS
Google Scholar
Henn BM, Botigue LR, Peischl S, Dupanloup I, Lipatov M, Maples BK, et al. Distance from sub-Saharan Africa predicts mutational load in diverse human genomes. Proc Natl Acad Sci U S A. 2016;113(4):E440–9.
Article
CAS
Google Scholar
Henn BM, Botigue LR, Bustamante CD, Clark AG, Gravel S. Estimating the mutation load in human genomes. Nat Rev Genet. 2015;16(6):333–43.
Article
CAS
Google Scholar
Genomes Project Consortium, Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, et al. A global reference for human genetic variation. Nature. 2015;526(7571):68–74.
Article
Google Scholar
Bouaoun L, Sonkin D, Ardin M, Hollstein M, Byrnes G, Zavadil J, et al. TP53 variations in human cancers: new lessons from the IARC TP53 database and genomics data. Hum Mutat. 2016;37(9):865–76.
Article
CAS
Google Scholar
Hnatyszyn A, Szalata M, Skrzypczak-Zielinska M, Wielgus K, Stanczyk J, Dziuba I, et al. DNA variants in helicobacter pylori infected patients with chronic gastritis, dysplasia and gastric cancer. Adv Med Sci. 2019;64(1):79–84.
Article
Google Scholar
Machlowska J, Kapusta P, Szlendak M, Bogdali A, Morsink F, Wolkow P, et al. Status of CHEK2 and p53 in patients with early-onset and conventional gastric cancer. Oncol Lett. 2021;21(5):348.
Article
CAS
Google Scholar
Gurzu S, Jung I, Sugimura H, Stefan-van Staden RI, Yamada H, Natsume H, et al. Maspin subcellular expression in wild-type and mutant TP53 gastric cancers. World J Gastrointest Oncol. 2020;12(7):741–55.
Article
Google Scholar
Kusafuka K, Yamada H, Ishino K, Maeda M, Yamanegi K, Baba S, et al. Salivary duct carcinoma with rhabdoid features-no or aberrant expression of E-cadherin and genetic changes in CDH1: immunohistochemical and genetic analyses of 17 cases. Am J Surg Pathol. 2021;45(4):439–49.
Article
Google Scholar
Godai TI, Suda T, Sugano N, Tsuchida K, Shiozawa M, Sekiguchi H, et al. Identification of colorectal cancer patients with tumors carrying the TP53 mutation on the codon 72 proline allele that benefited most from 5-fluorouracil (5-FU) based postoperative chemotherapy. BMC Cancer. 2009;9:420.
Article
Google Scholar
den Dunnen JT, Dalgleish R, Maglott DR, Hart RK, Greenblatt MS, McGowan-Jordan J, et al. HGVS recommendations for the description of sequence variants: 2016 update. Hum Mutat. 2016;37(6):564–9.
Article
Google Scholar
Hainaut P, Pfeifer GP. Somatic TP53 mutations in the era of genome sequencing. Cold Spring Harb Perspect Med. 2016;6(11):a026179.
Article
Google Scholar
Cerami E. The cBio cancer genomics portal: an open platform for eploring multidimensional cancer genomics data. Cancer Discov. 2012;2:401–4.
Article
Google Scholar
Degasperi A, Amarante TD, Czarnecki J, Shooter S, Zou X, Glodzik D, et al. A practical framework and online tool for mutational signature analyses show inter-tissue variation and driver dependencies. Nat Cancer. 2020;1(2):249–63.
Article
CAS
Google Scholar
Palli D, Caporaso NE, Shiao YH, Saieva C, Amorosi A, Masala G, et al. Diet, Helicobacter pylori, and p53 mutations in gastric cancer: a molecular epidemiology study in Italy. Cancer Epidemiol Biomark Prev. 1997;6(12):1065–9.
CAS
Google Scholar
Hongyo T, Buzard GS, Palli D, Weghorst CM, Amorosi A, Galli M, et al. Mutations of the K-ras and p53 genes in gastric adenocarcinomas from a high-incidence region around Florence, Italy. Cancer Res. 1995;55(12):2665–72.
CAS
Google Scholar
Yuan J, Hu Z, Mahal BA, Zhao SD, Kensler KH, Pi J, et al. Integrated analysis of genetic ancestry and genomic alterations across cancers. Cancer Cell. 2018;34(4):549–60.e9.
Article
CAS
Google Scholar
Carrot-Zhang J, Chambwe N, Damrauer JS, Knijnenburg TA, Robertson AG, Yau C, et al. Comprehensive analysis of genetic ancestry and its molecular correlates in cancer. Cancer Cell. 2020;37(5):639–54 e6.
Article
CAS
Google Scholar
Shiao YH, Palli D, Buzard GS, Caporaso NE, Amorosi A, Saieva C, et al. Implications of p53 mutation spectrum for cancer etiology in gastric cancers of various histologic types from a high-risk area of central Italy. Carcinogenesis. 1998;19(12):2145–9.
Article
CAS
Google Scholar
Correa P. The biological model of gastric carcinogenesis. IARC Sci Publ. 2004;157:301–10.
Google Scholar
Kawanishi S, Ohnishi S, Ma N, Hiraku Y, Oikawa S, Murata M. Nitrative and oxidative DNA damage in infection-related carcinogenesis in relation to cancer stem cells. Genes Environ. 2016;38:26.
Article
Google Scholar
Kawanishi S, Ohnishi S, Ma N, Hiraku Y, Murata M. Crosstalk between DNA damage and inflammation in the multiple steps of carcinogenesis. Int J Mol Sci. 2017;18(8):1808.
Ma N, Adachi Y, Hiraku Y, Horiki N, Horiike S, Imoto I, et al. Accumulation of 8-nitroguanine in human gastric epithelium induced by helicobacter pylori infection. Biochem Biophys Res Commun. 2004;319(2):506–10.
Article
CAS
Google Scholar
Kay J, Thadhani E, Samson L, Engelward B. Inflammation-induced DNA damage, mutations and cancer. DNA Repair (Amst). 2019;83:102673.
Article
CAS
Google Scholar
Duncan BK, Miller JH. Mutagenic deamination of cytosine residues in DNA. Nature. 1980;287(5782):560–1.
Article
CAS
Google Scholar
Kim YA, Leiserson MDM, Moorjani P, Sharan R, Wojtowicz D, Przytycka TM. Mutational signatures: from methods to mechanisms. Annu Rev Biomed Data Sci. 2021;4:189–206.
Article
Google Scholar
Pfeifer GP. Mutagenesis at methylated CpG sequences. Curr Top Microbiol Immunol. 2006;301:259–81.
CAS
Google Scholar
Sipponen P, Hyvarinen H, Seppala K, Blaser MJ. Review article: pathogenesis of the transformation from gastritis to malignancy. Aliment Pharmacol Ther. 1998;12(Suppl 1):61–71.
Article
CAS
Google Scholar
Hayashi Y, Tsujii M, Wang J, Kondo J, Akasaka T, Jin Y, et al. CagA mediates epigenetic regulation to attenuate let-7 expression in Helicobacter pylori-related carcinogenesis. Gut. 2013;62(11):1536–46.
Article
CAS
Google Scholar
Takeshima H, Niwa T, Yamashita S, Takamura-Enya T, Iida N, Wakabayashi M, et al. TET repression and increased DNMT activity synergistically induce aberrant DNA methylation. J Clin Invest. 2020;130(10):5370–9.
Article
CAS
Google Scholar
Cupid BC, Zeng Z, Singh R, Shuker DE. Detection of O6-carboxymethyl-2′-deoxyguanosine in DNA following reaction of nitric oxide with glycine and in human blood DNA using a quantitative immunoslot blot assay. Chem Res Toxicol. 2004;17(3):294–300.
Article
CAS
Google Scholar
Sugimura T, Fujimura S. Tumour production in glandular stomach of rat by N-methyl-N′-nitro-N-nitrosoguanidine. Nature. 1967;216(5118):943–4.
Article
CAS
Google Scholar
Mirvish SS. Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC. Cancer Lett. 1995;93(1):17–48.
Article
CAS
Google Scholar
Yasui M, Suenaga E, Koyama N, Masutani C, Hanaoka F, Gruz P, et al. Miscoding properties of 2′-deoxyinosine, a nitric oxide-derived DNA Adduct, during translesion synthesis catalyzed by human DNA polymerases. J Mol Biol. 2008;377(4):1015–23.
Article
CAS
Google Scholar
Wang JS, Wang YS. Carboxymethylation of DNA induced by N-nitroso compounds and its bioological implications. In: Advances in molecular toxicology: volume 5, chapter 6, p. 210-43 Elsevier; 2011. https://doi.org/10.1016/B978-0-444-53864-2.00006-2.
Matsuda T, Tao H, Goto M, Yamada H, Suzuki M, Wu Y, et al. Lipid peroxidation-induced DNA adducts in human gastric mucosa. Carcinogenesis. 2013;34(1):121–7.
Article
CAS
Google Scholar
Ohnishi I, Iwashita Y, Matsushita Y, Ohtsuka S, Yamashita T, Inaba K, et al. Mass spectrometric profiling of DNA adducts in the human stomach associated with damage from environmental factors. Genes Environ. 2021;43(1):12.
Article
CAS
Google Scholar
Iwashita Y, Ohnishi I, Matsushita Y, Ohtsuka S, Yamashita T, Inaba K, et al. Geospatial assessments of DNA adducts in the human stomach: a model of field cancerization. Cancers (Basel). 2021;13(15):3728.
Article
CAS
Google Scholar
Lee DH, Kim TH, Lee SY, Kim HJ, Rhee SK, Yoon B, et al. Mutations induced by 1,3-butadiene metabolites, butadiene diolepoxide, and 1,2,3,4-diepoxybutane at the Hprt locus in CHO-K1 cells. Mol Cells. 2002;14(3):411–9.
CAS
Google Scholar
Interntional Agency for Research on Cancer. IARC monograph. Eval Carcinog Risks Hum. 2008;97:3–471.
Google Scholar
Bobrovnitchaia I, Valieris R, Drummond RD, Lima JP, Freitas HC, Bartelli TF, et al. APOBEC-mediated DNA alterations: a possible new mechanism of carcinogenesis in EBV-positive gastric cancer. Int J Cancer. 2020;146(1):181–91.
Article
CAS
Google Scholar
Moody S, Senkin S, Islam SMA, Wang J, Nasrollahzadeh D, Cortez Cardoso Penha R, et al. Mutational signatures in esophageal squamous cell carcinoma from eight countries with varying incidence. Nat Genet. 2021;53(11):1553–63.
Article
CAS
Google Scholar
Kato S, Shields PG, Caporaso NE, Hoover RN, Trump BF, Sugimura H, et al. Cytochrome P450IIE1 genetic polymorphisms, racial variation, and lung cancer risk. Cancer Res. 1992;52(23):6712–5.
CAS
Google Scholar
Brennan P, Lewis S, Hashibe M, Bell DA, Boffetta P, Bouchardy C, et al. Pooled analysis of alcohol dehydrogenase genotypes and head and neck cancer: a HuGE review. Am J Epidemiol. 2004;159(1):1–16.
Article
Google Scholar
Suzuki A, Katoh H, Komura D, Kakiuchi M, Tagashira A, Yamamoto S, et al. Defined lifestyle and germline factors predispose Asian populations to gastric cancer. Sci Adv. 2020;6(19):eaav9778.
Article
CAS
Google Scholar
Mimaki S, Watanabe M, Kinoshita M, Yamashita R, Haeno H, Takemura S, et al. Multifocal origin of occupational cholangiocarcinoma revealed by comparison of multilesion mutational profiles. Carcinogenesis. 2020;41(3):368–76.
Article
CAS
Google Scholar
Ishino K, Yamada H, Kahyo T, Hino R, Nakamura M, Shimajiri S, et al. Comparison of p53 mutation analysis findings for tar pitch dermatopathy and ionizing radiation-related skin cancer. J Lab Precis Med. 2022;7:11. https://doi.org/10.21037/jlpm-21-69.
Sugimura H. Susceptibility to human cancer: from the perspective of a pathologist. Pathol Int. 2016;66(7):359–68.
Article
Google Scholar
Wang JL, Fu YD, Gao YH, Li XP, Xiong Q, Li R, et al. Unique characteristics of G719X and S768I compound double mutations of epidermal growth factor receptor (EGFR) gene in lung cancer of coal-producing areas of East Yunnan in southwestern China. Genes Environ. 2022;44(1):17.
Article
CAS
Google Scholar